Maybe Keith2, although an update on wafer clinical trials around the corner and I am sure the two new executives will want to hit the ground running.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025